nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—Alzheimer's disease	0.387	0.678	CbGaD
Pomalidomide—PTGS2—Alzheimer's disease	0.184	0.322	CbGaD
Pomalidomide—CYP3A4—Rivastigmine—Alzheimer's disease	0.0589	0.432	CbGbCtD
Pomalidomide—CYP3A4—Donepezil—Alzheimer's disease	0.0471	0.345	CbGbCtD
Pomalidomide—CYP3A4—Galantamine—Alzheimer's disease	0.0303	0.223	CbGbCtD
Pomalidomide—CRBN—embryo—Alzheimer's disease	0.00207	0.135	CbGeAlD
Pomalidomide—CRBN—forebrain—Alzheimer's disease	0.00183	0.12	CbGeAlD
Pomalidomide—CRBN—telencephalon—Alzheimer's disease	0.00168	0.11	CbGeAlD
Pomalidomide—Thalidomide—TNF—Alzheimer's disease	0.00139	0.323	CrCbGaD
Pomalidomide—Thalidomide—PTGS1—Alzheimer's disease	0.00116	0.268	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—Alzheimer's disease	0.0011	0.256	CrCbGaD
Pomalidomide—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00101	0.00591	CcSEcCtD
Pomalidomide—Sepsis—Memantine—Alzheimer's disease	0.000998	0.00582	CcSEcCtD
Pomalidomide—CRBN—nervous system—Alzheimer's disease	0.000993	0.065	CbGeAlD
Pomalidomide—Bronchitis—Galantamine—Alzheimer's disease	0.000986	0.00575	CcSEcCtD
Pomalidomide—Sepsis—Rivastigmine—Alzheimer's disease	0.000976	0.00569	CcSEcCtD
Pomalidomide—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00097	0.00566	CcSEcCtD
Pomalidomide—CRBN—central nervous system—Alzheimer's disease	0.000956	0.0626	CbGeAlD
Pomalidomide—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000953	0.00556	CcSEcCtD
Pomalidomide—PTGS2—blood vessel—Alzheimer's disease	0.000944	0.0618	CbGeAlD
Pomalidomide—CRBN—cerebellum—Alzheimer's disease	0.000934	0.0612	CbGeAlD
Pomalidomide—Weight decreased—Galantamine—Alzheimer's disease	0.000927	0.00541	CcSEcCtD
Pomalidomide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.000925	0.00539	CcSEcCtD
Pomalidomide—Hyponatraemia—Donepezil—Alzheimer's disease	0.000923	0.00538	CcSEcCtD
Pomalidomide—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00092	0.00537	CcSEcCtD
Pomalidomide—Pneumonia—Galantamine—Alzheimer's disease	0.000919	0.00536	CcSEcCtD
Pomalidomide—Renal failure—Galantamine—Alzheimer's disease	0.000898	0.00524	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000896	0.00522	CcSEcCtD
Pomalidomide—Urinary tract infection—Galantamine—Alzheimer's disease	0.000888	0.00518	CcSEcCtD
Pomalidomide—Atrial fibrillation—Memantine—Alzheimer's disease	0.000881	0.00514	CcSEcCtD
Pomalidomide—Urinary retention—Donepezil—Alzheimer's disease	0.000874	0.0051	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000864	0.00504	CcSEcCtD
Pomalidomide—Epistaxis—Galantamine—Alzheimer's disease	0.000862	0.00503	CcSEcCtD
Pomalidomide—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.000861	0.00502	CcSEcCtD
Pomalidomide—Blood creatinine increased—Donepezil—Alzheimer's disease	0.000861	0.00502	CcSEcCtD
Pomalidomide—Dehydration—Donepezil—Alzheimer's disease	0.000855	0.00498	CcSEcCtD
Pomalidomide—Dry skin—Donepezil—Alzheimer's disease	0.000842	0.00491	CcSEcCtD
Pomalidomide—Hyponatraemia—Memantine—Alzheimer's disease	0.000838	0.00489	CcSEcCtD
Pomalidomide—Hypokalaemia—Donepezil—Alzheimer's disease	0.000836	0.00488	CcSEcCtD
Pomalidomide—Pain in extremity—Memantine—Alzheimer's disease	0.000835	0.00487	CcSEcCtD
Pomalidomide—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000822	0.00479	CcSEcCtD
Pomalidomide—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00082	0.00478	CcSEcCtD
Pomalidomide—Pain in extremity—Rivastigmine—Alzheimer's disease	0.000816	0.00476	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.000811	0.00473	CcSEcCtD
Pomalidomide—Muscular weakness—Donepezil—Alzheimer's disease	0.000811	0.00473	CcSEcCtD
Pomalidomide—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00081	0.00472	CcSEcCtD
Pomalidomide—Oedema peripheral—Galantamine—Alzheimer's disease	0.000808	0.00471	CcSEcCtD
Pomalidomide—Connective tissue disorder—Galantamine—Alzheimer's disease	0.000806	0.0047	CcSEcCtD
Pomalidomide—Urethral disorder—Galantamine—Alzheimer's disease	0.000804	0.00469	CcSEcCtD
Pomalidomide—Urinary retention—Memantine—Alzheimer's disease	0.000794	0.00463	CcSEcCtD
Pomalidomide—Blood creatinine increased—Memantine—Alzheimer's disease	0.000782	0.00456	CcSEcCtD
Pomalidomide—Urinary retention—Rivastigmine—Alzheimer's disease	0.000776	0.00453	CcSEcCtD
Pomalidomide—Dehydration—Memantine—Alzheimer's disease	0.000776	0.00453	CcSEcCtD
Pomalidomide—Dry skin—Memantine—Alzheimer's disease	0.000765	0.00446	CcSEcCtD
Pomalidomide—Bronchitis—Donepezil—Alzheimer's disease	0.000764	0.00445	CcSEcCtD
Pomalidomide—Cardiac disorder—Galantamine—Alzheimer's disease	0.000761	0.00444	CcSEcCtD
Pomalidomide—Hypokalaemia—Memantine—Alzheimer's disease	0.000759	0.00443	CcSEcCtD
Pomalidomide—Dehydration—Rivastigmine—Alzheimer's disease	0.000759	0.00443	CcSEcCtD
Pomalidomide—CRBN—brain—Alzheimer's disease	0.000759	0.0497	CbGeAlD
Pomalidomide—Dry skin—Rivastigmine—Alzheimer's disease	0.000748	0.00436	CcSEcCtD
Pomalidomide—Nasopharyngitis—Memantine—Alzheimer's disease	0.000746	0.00435	CcSEcCtD
Pomalidomide—Angiopathy—Galantamine—Alzheimer's disease	0.000744	0.00434	CcSEcCtD
Pomalidomide—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000743	0.00433	CcSEcCtD
Pomalidomide—Breast disorder—Rivastigmine—Alzheimer's disease	0.000738	0.0043	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.000736	0.00429	CcSEcCtD
Pomalidomide—Muscular weakness—Memantine—Alzheimer's disease	0.000736	0.00429	CcSEcCtD
Pomalidomide—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00073	0.00426	CcSEcCtD
Pomalidomide—Weight increased—Donepezil—Alzheimer's disease	0.000723	0.00422	CcSEcCtD
Pomalidomide—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00072	0.0042	CcSEcCtD
Pomalidomide—Mental disorder—Galantamine—Alzheimer's disease	0.000719	0.00419	CcSEcCtD
Pomalidomide—Weight decreased—Donepezil—Alzheimer's disease	0.000719	0.00419	CcSEcCtD
Pomalidomide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000717	0.00418	CcSEcCtD
Pomalidomide—Malnutrition—Galantamine—Alzheimer's disease	0.000714	0.00416	CcSEcCtD
Pomalidomide—Pneumonia—Donepezil—Alzheimer's disease	0.000712	0.00415	CcSEcCtD
Pomalidomide—Infestation—Donepezil—Alzheimer's disease	0.000708	0.00413	CcSEcCtD
Pomalidomide—Infestation NOS—Donepezil—Alzheimer's disease	0.000708	0.00413	CcSEcCtD
Pomalidomide—Renal failure—Donepezil—Alzheimer's disease	0.000696	0.00406	CcSEcCtD
Pomalidomide—Bronchitis—Memantine—Alzheimer's disease	0.000694	0.00404	CcSEcCtD
Pomalidomide—Back pain—Galantamine—Alzheimer's disease	0.000691	0.00403	CcSEcCtD
Pomalidomide—Urinary tract infection—Donepezil—Alzheimer's disease	0.000688	0.00401	CcSEcCtD
Pomalidomide—Muscle spasms—Galantamine—Alzheimer's disease	0.000687	0.004	CcSEcCtD
Pomalidomide—Pancytopenia—Memantine—Alzheimer's disease	0.000685	0.00399	CcSEcCtD
Pomalidomide—Bronchitis—Rivastigmine—Alzheimer's disease	0.000679	0.00396	CcSEcCtD
Pomalidomide—Neutropenia—Memantine—Alzheimer's disease	0.000674	0.00393	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00067	0.00391	CcSEcCtD
Pomalidomide—Tremor—Galantamine—Alzheimer's disease	0.000669	0.0039	CcSEcCtD
Pomalidomide—Epistaxis—Donepezil—Alzheimer's disease	0.000668	0.0039	CcSEcCtD
Pomalidomide—Thalidomide—PTGS2—Alzheimer's disease	0.000661	0.153	CrCbGaD
Pomalidomide—Anaemia—Galantamine—Alzheimer's disease	0.00066	0.00385	CcSEcCtD
Pomalidomide—Weight increased—Memantine—Alzheimer's disease	0.000656	0.00383	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000656	0.00382	CcSEcCtD
Pomalidomide—Weight decreased—Memantine—Alzheimer's disease	0.000653	0.00381	CcSEcCtD
Pomalidomide—Hyperglycaemia—Memantine—Alzheimer's disease	0.000651	0.00379	CcSEcCtD
Pomalidomide—Pneumonia—Memantine—Alzheimer's disease	0.000647	0.00377	CcSEcCtD
Pomalidomide—Infestation NOS—Memantine—Alzheimer's disease	0.000643	0.00375	CcSEcCtD
Pomalidomide—Infestation—Memantine—Alzheimer's disease	0.000643	0.00375	CcSEcCtD
Pomalidomide—Weight increased—Rivastigmine—Alzheimer's disease	0.000642	0.00374	CcSEcCtD
Pomalidomide—Vertigo—Galantamine—Alzheimer's disease	0.000642	0.00374	CcSEcCtD
Pomalidomide—Weight decreased—Rivastigmine—Alzheimer's disease	0.000638	0.00372	CcSEcCtD
Pomalidomide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000636	0.00371	CcSEcCtD
Pomalidomide—Pneumonia—Rivastigmine—Alzheimer's disease	0.000633	0.00369	CcSEcCtD
Pomalidomide—Renal failure—Memantine—Alzheimer's disease	0.000632	0.00369	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00063	0.00368	CcSEcCtD
Pomalidomide—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000629	0.00367	CcSEcCtD
Pomalidomide—Infestation—Rivastigmine—Alzheimer's disease	0.000629	0.00367	CcSEcCtD
Pomalidomide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000628	0.00366	CcSEcCtD
Pomalidomide—Oedema peripheral—Donepezil—Alzheimer's disease	0.000626	0.00365	CcSEcCtD
Pomalidomide—Urinary tract infection—Memantine—Alzheimer's disease	0.000625	0.00365	CcSEcCtD
Pomalidomide—Urethral disorder—Donepezil—Alzheimer's disease	0.000623	0.00363	CcSEcCtD
Pomalidomide—Cough—Galantamine—Alzheimer's disease	0.000623	0.00363	CcSEcCtD
Pomalidomide—Renal failure—Rivastigmine—Alzheimer's disease	0.000618	0.00361	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000617	0.0036	CcSEcCtD
Pomalidomide—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000612	0.00357	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000608	0.00355	CcSEcCtD
Pomalidomide—Arthralgia—Galantamine—Alzheimer's disease	0.000608	0.00355	CcSEcCtD
Pomalidomide—Epistaxis—Memantine—Alzheimer's disease	0.000607	0.00354	CcSEcCtD
Pomalidomide—Anxiety—Galantamine—Alzheimer's disease	0.000606	0.00353	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000604	0.00352	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000595	0.00347	CcSEcCtD
Pomalidomide—Epistaxis—Rivastigmine—Alzheimer's disease	0.000593	0.00346	CcSEcCtD
Pomalidomide—Confusional state—Galantamine—Alzheimer's disease	0.000588	0.00343	CcSEcCtD
Pomalidomide—ABCB1—blood vessel—Alzheimer's disease	0.000584	0.0382	CbGeAlD
Pomalidomide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000572	0.00333	CcSEcCtD
Pomalidomide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000571	0.00333	CcSEcCtD
Pomalidomide—Chills—Donepezil—Alzheimer's disease	0.00057	0.00333	CcSEcCtD
Pomalidomide—Urinary tract disorder—Memantine—Alzheimer's disease	0.00057	0.00332	CcSEcCtD
Pomalidomide—Oedema peripheral—Memantine—Alzheimer's disease	0.000569	0.00332	CcSEcCtD
Pomalidomide—Connective tissue disorder—Memantine—Alzheimer's disease	0.000567	0.00331	CcSEcCtD
Pomalidomide—Skin disorder—Galantamine—Alzheimer's disease	0.000566	0.0033	CcSEcCtD
Pomalidomide—Urethral disorder—Memantine—Alzheimer's disease	0.000566	0.0033	CcSEcCtD
Pomalidomide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000563	0.00329	CcSEcCtD
Pomalidomide—PTGS2—embryo—Alzheimer's disease	0.000563	0.0369	CbGeAlD
Pomalidomide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000558	0.00325	CcSEcCtD
Pomalidomide—Mental disorder—Donepezil—Alzheimer's disease	0.000557	0.00325	CcSEcCtD
Pomalidomide—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000556	0.00324	CcSEcCtD
Pomalidomide—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000555	0.00324	CcSEcCtD
Pomalidomide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000554	0.00323	CcSEcCtD
Pomalidomide—Malnutrition—Donepezil—Alzheimer's disease	0.000553	0.00323	CcSEcCtD
Pomalidomide—Cardiac disorder—Memantine—Alzheimer's disease	0.000536	0.00312	CcSEcCtD
Pomalidomide—Back pain—Donepezil—Alzheimer's disease	0.000535	0.00312	CcSEcCtD
Pomalidomide—Muscle spasms—Donepezil—Alzheimer's disease	0.000532	0.0031	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000531	0.0031	CcSEcCtD
Pomalidomide—Insomnia—Galantamine—Alzheimer's disease	0.000527	0.00307	CcSEcCtD
Pomalidomide—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000524	0.00306	CcSEcCtD
Pomalidomide—Angiopathy—Memantine—Alzheimer's disease	0.000524	0.00305	CcSEcCtD
Pomalidomide—Mediastinal disorder—Memantine—Alzheimer's disease	0.00052	0.00303	CcSEcCtD
Pomalidomide—Tremor—Donepezil—Alzheimer's disease	0.000519	0.00302	CcSEcCtD
Pomalidomide—Chills—Memantine—Alzheimer's disease	0.000518	0.00302	CcSEcCtD
Pomalidomide—Angiopathy—Rivastigmine—Alzheimer's disease	0.000512	0.00299	CcSEcCtD
Pomalidomide—Anaemia—Donepezil—Alzheimer's disease	0.000512	0.00298	CcSEcCtD
Pomalidomide—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000509	0.00297	CcSEcCtD
Pomalidomide—Chills—Rivastigmine—Alzheimer's disease	0.000507	0.00296	CcSEcCtD
Pomalidomide—Decreased appetite—Galantamine—Alzheimer's disease	0.000507	0.00295	CcSEcCtD
Pomalidomide—Mental disorder—Memantine—Alzheimer's disease	0.000506	0.00295	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000503	0.00293	CcSEcCtD
Pomalidomide—Malnutrition—Memantine—Alzheimer's disease	0.000503	0.00293	CcSEcCtD
Pomalidomide—Fatigue—Galantamine—Alzheimer's disease	0.000503	0.00293	CcSEcCtD
Pomalidomide—Constipation—Galantamine—Alzheimer's disease	0.000498	0.00291	CcSEcCtD
Pomalidomide—PTGS2—forebrain—Alzheimer's disease	0.000498	0.0326	CbGeAlD
Pomalidomide—Vertigo—Donepezil—Alzheimer's disease	0.000497	0.0029	CcSEcCtD
Pomalidomide—Mental disorder—Rivastigmine—Alzheimer's disease	0.000495	0.00289	CcSEcCtD
Pomalidomide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000492	0.00287	CcSEcCtD
Pomalidomide—Back pain—Memantine—Alzheimer's disease	0.000486	0.00283	CcSEcCtD
Pomalidomide—Cough—Donepezil—Alzheimer's disease	0.000483	0.00282	CcSEcCtD
Pomalidomide—Feeling abnormal—Galantamine—Alzheimer's disease	0.00048	0.0028	CcSEcCtD
Pomalidomide—Back pain—Rivastigmine—Alzheimer's disease	0.000476	0.00277	CcSEcCtD
Pomalidomide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000473	0.00276	CcSEcCtD
Pomalidomide—Arthralgia—Donepezil—Alzheimer's disease	0.000471	0.00275	CcSEcCtD
Pomalidomide—Tremor—Memantine—Alzheimer's disease	0.000471	0.00275	CcSEcCtD
Pomalidomide—Anxiety—Donepezil—Alzheimer's disease	0.00047	0.00274	CcSEcCtD
Pomalidomide—Anaemia—Memantine—Alzheimer's disease	0.000464	0.00271	CcSEcCtD
Pomalidomide—Body temperature increased—Galantamine—Alzheimer's disease	0.000461	0.00269	CcSEcCtD
Pomalidomide—Tremor—Rivastigmine—Alzheimer's disease	0.000461	0.00269	CcSEcCtD
Pomalidomide—PTGS2—telencephalon—Alzheimer's disease	0.000458	0.03	CbGeAlD
Pomalidomide—Confusional state—Donepezil—Alzheimer's disease	0.000455	0.00266	CcSEcCtD
Pomalidomide—Anaemia—Rivastigmine—Alzheimer's disease	0.000454	0.00265	CcSEcCtD
Pomalidomide—Vertigo—Memantine—Alzheimer's disease	0.000452	0.00263	CcSEcCtD
Pomalidomide—Leukopenia—Memantine—Alzheimer's disease	0.00045	0.00262	CcSEcCtD
Pomalidomide—Infection—Donepezil—Alzheimer's disease	0.000449	0.00262	CcSEcCtD
Pomalidomide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000443	0.00258	CcSEcCtD
Pomalidomide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000442	0.00258	CcSEcCtD
Pomalidomide—Vertigo—Rivastigmine—Alzheimer's disease	0.000442	0.00258	CcSEcCtD
Pomalidomide—Cough—Memantine—Alzheimer's disease	0.000439	0.00256	CcSEcCtD
Pomalidomide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000437	0.00255	CcSEcCtD
Pomalidomide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000429	0.0025	CcSEcCtD
Pomalidomide—Cough—Rivastigmine—Alzheimer's disease	0.000429	0.0025	CcSEcCtD
Pomalidomide—Arthralgia—Memantine—Alzheimer's disease	0.000428	0.0025	CcSEcCtD
Pomalidomide—Anxiety—Memantine—Alzheimer's disease	0.000426	0.00249	CcSEcCtD
Pomalidomide—Arthralgia—Rivastigmine—Alzheimer's disease	0.000419	0.00244	CcSEcCtD
Pomalidomide—Asthenia—Galantamine—Alzheimer's disease	0.000418	0.00244	CcSEcCtD
Pomalidomide—Anxiety—Rivastigmine—Alzheimer's disease	0.000417	0.00243	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000416	0.00242	CcSEcCtD
Pomalidomide—Confusional state—Memantine—Alzheimer's disease	0.000414	0.00241	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000412	0.0024	CcSEcCtD
Pomalidomide—Insomnia—Donepezil—Alzheimer's disease	0.000409	0.00238	CcSEcCtD
Pomalidomide—Infection—Memantine—Alzheimer's disease	0.000407	0.00238	CcSEcCtD
Pomalidomide—Confusional state—Rivastigmine—Alzheimer's disease	0.000405	0.00236	CcSEcCtD
Pomalidomide—Dyspnoea—Donepezil—Alzheimer's disease	0.000403	0.00235	CcSEcCtD
Pomalidomide—Nervous system disorder—Memantine—Alzheimer's disease	0.000402	0.00235	CcSEcCtD
Pomalidomide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000402	0.00234	CcSEcCtD
Pomalidomide—Diarrhoea—Galantamine—Alzheimer's disease	0.000399	0.00233	CcSEcCtD
Pomalidomide—Infection—Rivastigmine—Alzheimer's disease	0.000399	0.00232	CcSEcCtD
Pomalidomide—Skin disorder—Memantine—Alzheimer's disease	0.000398	0.00232	CcSEcCtD
Pomalidomide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000397	0.00231	CcSEcCtD
Pomalidomide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000393	0.00229	CcSEcCtD
Pomalidomide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000393	0.00229	CcSEcCtD
Pomalidomide—Decreased appetite—Donepezil—Alzheimer's disease	0.000393	0.00229	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00039	0.00227	CcSEcCtD
Pomalidomide—Skin disorder—Rivastigmine—Alzheimer's disease	0.00039	0.00227	CcSEcCtD
Pomalidomide—Fatigue—Donepezil—Alzheimer's disease	0.000389	0.00227	CcSEcCtD
Pomalidomide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000388	0.00226	CcSEcCtD
Pomalidomide—Constipation—Donepezil—Alzheimer's disease	0.000386	0.00225	CcSEcCtD
Pomalidomide—Pain—Donepezil—Alzheimer's disease	0.000386	0.00225	CcSEcCtD
Pomalidomide—Dizziness—Galantamine—Alzheimer's disease	0.000385	0.00225	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000374	0.00218	CcSEcCtD
Pomalidomide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000372	0.00217	CcSEcCtD
Pomalidomide—Insomnia—Memantine—Alzheimer's disease	0.000371	0.00216	CcSEcCtD
Pomalidomide—Vomiting—Galantamine—Alzheimer's disease	0.000371	0.00216	CcSEcCtD
Pomalidomide—Rash—Galantamine—Alzheimer's disease	0.000368	0.00214	CcSEcCtD
Pomalidomide—Dermatitis—Galantamine—Alzheimer's disease	0.000367	0.00214	CcSEcCtD
Pomalidomide—Dyspnoea—Memantine—Alzheimer's disease	0.000366	0.00213	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000366	0.00213	CcSEcCtD
Pomalidomide—Headache—Galantamine—Alzheimer's disease	0.000365	0.00213	CcSEcCtD
Pomalidomide—Insomnia—Rivastigmine—Alzheimer's disease	0.000363	0.00212	CcSEcCtD
Pomalidomide—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000358	0.00209	CcSEcCtD
Pomalidomide—Body temperature increased—Donepezil—Alzheimer's disease	0.000357	0.00208	CcSEcCtD
Pomalidomide—Decreased appetite—Memantine—Alzheimer's disease	0.000357	0.00208	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000354	0.00206	CcSEcCtD
Pomalidomide—Fatigue—Memantine—Alzheimer's disease	0.000354	0.00206	CcSEcCtD
Pomalidomide—Constipation—Memantine—Alzheimer's disease	0.000351	0.00205	CcSEcCtD
Pomalidomide—Pain—Memantine—Alzheimer's disease	0.000351	0.00205	CcSEcCtD
Pomalidomide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000349	0.00203	CcSEcCtD
Pomalidomide—ABCB1—embryo—Alzheimer's disease	0.000348	0.0228	CbGeAlD
Pomalidomide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000346	0.00202	CcSEcCtD
Pomalidomide—Nausea—Galantamine—Alzheimer's disease	0.000346	0.00202	CcSEcCtD
Pomalidomide—Fatigue—Rivastigmine—Alzheimer's disease	0.000346	0.00202	CcSEcCtD
Pomalidomide—Constipation—Rivastigmine—Alzheimer's disease	0.000343	0.002	CcSEcCtD
Pomalidomide—Pain—Rivastigmine—Alzheimer's disease	0.000343	0.002	CcSEcCtD
Pomalidomide—Feeling abnormal—Memantine—Alzheimer's disease	0.000338	0.00197	CcSEcCtD
Pomalidomide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000333	0.00194	CcSEcCtD
Pomalidomide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000331	0.00193	CcSEcCtD
Pomalidomide—Body temperature increased—Memantine—Alzheimer's disease	0.000324	0.00189	CcSEcCtD
Pomalidomide—Asthenia—Donepezil—Alzheimer's disease	0.000324	0.00189	CcSEcCtD
Pomalidomide—Pruritus—Donepezil—Alzheimer's disease	0.00032	0.00186	CcSEcCtD
Pomalidomide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000317	0.00185	CcSEcCtD
Pomalidomide—Diarrhoea—Donepezil—Alzheimer's disease	0.000309	0.0018	CcSEcCtD
Pomalidomide—ABCB1—forebrain—Alzheimer's disease	0.000308	0.0202	CbGeAlD
Pomalidomide—Hypersensitivity—Memantine—Alzheimer's disease	0.000302	0.00176	CcSEcCtD
Pomalidomide—Dizziness—Donepezil—Alzheimer's disease	0.000299	0.00174	CcSEcCtD
Pomalidomide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000296	0.00172	CcSEcCtD
Pomalidomide—Asthenia—Memantine—Alzheimer's disease	0.000294	0.00172	CcSEcCtD
Pomalidomide—Pruritus—Memantine—Alzheimer's disease	0.00029	0.00169	CcSEcCtD
Pomalidomide—Asthenia—Rivastigmine—Alzheimer's disease	0.000288	0.00168	CcSEcCtD
Pomalidomide—Vomiting—Donepezil—Alzheimer's disease	0.000287	0.00167	CcSEcCtD
Pomalidomide—Rash—Donepezil—Alzheimer's disease	0.000285	0.00166	CcSEcCtD
Pomalidomide—Dermatitis—Donepezil—Alzheimer's disease	0.000285	0.00166	CcSEcCtD
Pomalidomide—Pruritus—Rivastigmine—Alzheimer's disease	0.000284	0.00166	CcSEcCtD
Pomalidomide—ABCB1—telencephalon—Alzheimer's disease	0.000283	0.0185	CbGeAlD
Pomalidomide—Headache—Donepezil—Alzheimer's disease	0.000283	0.00165	CcSEcCtD
Pomalidomide—Diarrhoea—Memantine—Alzheimer's disease	0.000281	0.00164	CcSEcCtD
Pomalidomide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000275	0.0016	CcSEcCtD
Pomalidomide—Dizziness—Memantine—Alzheimer's disease	0.000271	0.00158	CcSEcCtD
Pomalidomide—PTGS2—nervous system—Alzheimer's disease	0.00027	0.0177	CbGeAlD
Pomalidomide—Nausea—Donepezil—Alzheimer's disease	0.000268	0.00156	CcSEcCtD
Pomalidomide—Dizziness—Rivastigmine—Alzheimer's disease	0.000265	0.00155	CcSEcCtD
Pomalidomide—Vomiting—Memantine—Alzheimer's disease	0.000261	0.00152	CcSEcCtD
Pomalidomide—PTGS2—central nervous system—Alzheimer's disease	0.00026	0.017	CbGeAlD
Pomalidomide—Rash—Memantine—Alzheimer's disease	0.000259	0.00151	CcSEcCtD
Pomalidomide—Dermatitis—Memantine—Alzheimer's disease	0.000258	0.00151	CcSEcCtD
Pomalidomide—Headache—Memantine—Alzheimer's disease	0.000257	0.0015	CcSEcCtD
Pomalidomide—Vomiting—Rivastigmine—Alzheimer's disease	0.000255	0.00149	CcSEcCtD
Pomalidomide—PTGS2—cerebellum—Alzheimer's disease	0.000254	0.0167	CbGeAlD
Pomalidomide—Rash—Rivastigmine—Alzheimer's disease	0.000253	0.00148	CcSEcCtD
Pomalidomide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000253	0.00147	CcSEcCtD
Pomalidomide—Headache—Rivastigmine—Alzheimer's disease	0.000251	0.00147	CcSEcCtD
Pomalidomide—Nausea—Memantine—Alzheimer's disease	0.000244	0.00142	CcSEcCtD
Pomalidomide—Nausea—Rivastigmine—Alzheimer's disease	0.000238	0.00139	CcSEcCtD
Pomalidomide—CYP3A4—nervous system—Alzheimer's disease	0.000236	0.0155	CbGeAlD
Pomalidomide—CYP3A4—central nervous system—Alzheimer's disease	0.000227	0.0149	CbGeAlD
Pomalidomide—PTGS2—brain—Alzheimer's disease	0.000207	0.0135	CbGeAlD
Pomalidomide—ABCB1—nervous system—Alzheimer's disease	0.000167	0.0109	CbGeAlD
Pomalidomide—ABCB1—central nervous system—Alzheimer's disease	0.000161	0.0105	CbGeAlD
Pomalidomide—ABCB1—cerebellum—Alzheimer's disease	0.000157	0.0103	CbGeAlD
Pomalidomide—ABCB1—brain—Alzheimer's disease	0.000128	0.00837	CbGeAlD
Pomalidomide—TNF—Spinal Cord Injury—IL6—Alzheimer's disease	4.24e-05	0.000415	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	4.21e-05	0.000412	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	4.18e-05	0.000409	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.17e-05	0.000408	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	4.11e-05	0.000402	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	4.1e-05	0.000401	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.06e-05	0.000397	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	4.01e-05	0.000392	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	3.99e-05	0.00039	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	3.98e-05	0.000389	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.95e-05	0.000386	CbGpPWpGaD
Pomalidomide—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.92e-05	0.000384	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—Alzheimer's disease	3.92e-05	0.000384	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	3.91e-05	0.000382	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	3.91e-05	0.000382	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.83e-05	0.000374	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLD3—Alzheimer's disease	3.81e-05	0.000372	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.81e-05	0.000372	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.76e-05	0.000368	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DHCR24—Alzheimer's disease	3.73e-05	0.000365	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—Alzheimer's disease	3.72e-05	0.000364	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—Alzheimer's disease	3.72e-05	0.000364	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	3.7e-05	0.000362	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	3.65e-05	0.000357	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LEP—Alzheimer's disease	3.61e-05	0.000353	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.57e-05	0.000349	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	3.51e-05	0.000344	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TP53—Alzheimer's disease	3.49e-05	0.000341	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	3.48e-05	0.00034	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	3.45e-05	0.000337	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—AKT1—Alzheimer's disease	3.43e-05	0.000336	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	3.4e-05	0.000333	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ND1—Alzheimer's disease	3.39e-05	0.000332	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	3.39e-05	0.000332	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NOTCH1—Alzheimer's disease	3.33e-05	0.000326	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	3.32e-05	0.000324	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	3.32e-05	0.000324	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	3.25e-05	0.000318	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SNCA—Alzheimer's disease	3.24e-05	0.000317	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.23e-05	0.000316	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	3.17e-05	0.000311	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CA4—Alzheimer's disease	3.17e-05	0.00031	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.15e-05	0.000308	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—Alzheimer's disease	3.15e-05	0.000308	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—AKT1—Alzheimer's disease	3.14e-05	0.000308	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—GSK3B—Alzheimer's disease	3.13e-05	0.000306	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—CREB1—Alzheimer's disease	3.1e-05	0.000304	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—Alzheimer's disease	3.09e-05	0.000302	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	3.04e-05	0.000297	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.03e-05	0.000297	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	2.98e-05	0.000292	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.98e-05	0.000291	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.95e-05	0.000289	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—AKT1—Alzheimer's disease	2.95e-05	0.000288	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	2.91e-05	0.000285	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PSENEN—Alzheimer's disease	2.89e-05	0.000282	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	2.86e-05	0.00028	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APH1A—Alzheimer's disease	2.85e-05	0.000278	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	2.83e-05	0.000277	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	2.8e-05	0.000274	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.79e-05	0.000273	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.78e-05	0.000272	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NCSTN—Alzheimer's disease	2.77e-05	0.000271	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	2.73e-05	0.000267	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LRP1—Alzheimer's disease	2.7e-05	0.000264	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLD3—Alzheimer's disease	2.7e-05	0.000264	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.66e-05	0.00026	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	2.62e-05	0.000256	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.61e-05	0.000256	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TPI1—Alzheimer's disease	2.61e-05	0.000255	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	2.59e-05	0.000253	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.58e-05	0.000252	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CA4—Alzheimer's disease	2.53e-05	0.000248	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.51e-05	0.000245	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	2.49e-05	0.000244	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.48e-05	0.000242	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EIF2AK2—Alzheimer's disease	2.45e-05	0.00024	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.44e-05	0.000239	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GAPDH—Alzheimer's disease	2.41e-05	0.000236	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ND1—Alzheimer's disease	2.41e-05	0.000235	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	2.38e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.38e-05	0.000233	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	2.37e-05	0.000232	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.32e-05	0.000227	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.3e-05	0.000225	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	2.26e-05	0.000221	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PSEN2—Alzheimer's disease	2.25e-05	0.00022	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	2.21e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CST3—Alzheimer's disease	2.2e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—TPI1—Alzheimer's disease	2.19e-05	0.000214	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CHAT—Alzheimer's disease	2.19e-05	0.000214	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLD3—Alzheimer's disease	2.15e-05	0.000211	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.15e-05	0.000211	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.15e-05	0.000211	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.13e-05	0.000208	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MAOB—Alzheimer's disease	2.1e-05	0.000205	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	2.07e-05	0.000202	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IAPP—Alzheimer's disease	2.06e-05	0.000202	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.02e-05	0.000197	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GAPDH—Alzheimer's disease	2.02e-05	0.000197	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.99e-05	0.000195	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.99e-05	0.000194	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.98e-05	0.000194	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.98e-05	0.000193	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.96e-05	0.000191	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—VEGFA—Alzheimer's disease	1.95e-05	0.000191	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—A2M—Alzheimer's disease	1.95e-05	0.000191	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.95e-05	0.000191	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.92e-05	0.000188	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ENO1—Alzheimer's disease	1.9e-05	0.000186	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.89e-05	0.000185	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.88e-05	0.000184	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.84e-05	0.00018	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.83e-05	0.000179	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GAB2—Alzheimer's disease	1.81e-05	0.000177	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3A—Alzheimer's disease	1.79e-05	0.000175	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—Alzheimer's disease	1.79e-05	0.000175	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APP—Alzheimer's disease	1.76e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.75e-05	0.000172	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.74e-05	0.00017	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.74e-05	0.00017	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.72e-05	0.000168	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.7e-05	0.000166	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.68e-05	0.000164	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.68e-05	0.000164	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.66e-05	0.000163	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.65e-05	0.000161	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.59e-05	0.000156	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.59e-05	0.000155	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.59e-05	0.000155	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.57e-05	0.000153	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.56e-05	0.000152	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.55e-05	0.000152	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.55e-05	0.000152	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.53e-05	0.00015	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADAM10—Alzheimer's disease	1.52e-05	0.000148	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.49e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.48e-05	0.000145	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.48e-05	0.000145	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.48e-05	0.000144	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.43e-05	0.00014	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PLCB1—Alzheimer's disease	1.39e-05	0.000136	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—A2M—Alzheimer's disease	1.38e-05	0.000135	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.38e-05	0.000135	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCA1—Alzheimer's disease	1.35e-05	0.000132	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—Alzheimer's disease	1.35e-05	0.000132	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.35e-05	0.000132	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LPL—Alzheimer's disease	1.27e-05	0.000124	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—AKT1—Alzheimer's disease	1.24e-05	0.000122	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CHAT—Alzheimer's disease	1.24e-05	0.000121	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—TPI1—Alzheimer's disease	1.24e-05	0.000121	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRKCG—Alzheimer's disease	1.23e-05	0.00012	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.2e-05	0.000118	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.19e-05	0.000116	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MAOB—Alzheimer's disease	1.19e-05	0.000116	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.17e-05	0.000114	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—Alzheimer's disease	1.17e-05	0.000114	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	1.16e-05	0.000114	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HMOX1—Alzheimer's disease	1.16e-05	0.000113	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	1.14e-05	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MTHFR—Alzheimer's disease	1.14e-05	0.000111	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.13e-05	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.13e-05	0.00011	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.13e-05	0.00011	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.12e-05	0.000109	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.1e-05	0.000108	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—A2M—Alzheimer's disease	1.1e-05	0.000108	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CALM1—Alzheimer's disease	1.06e-05	0.000104	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOE—Alzheimer's disease	1.06e-05	0.000104	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—LPL—Alzheimer's disease	1.06e-05	0.000104	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CAV1—Alzheimer's disease	1.05e-05	0.000103	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.05e-05	0.000102	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—Alzheimer's disease	9.89e-06	9.67e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PLCB1—Alzheimer's disease	9.88e-06	9.66e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.83e-06	9.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOTCH1—Alzheimer's disease	9.79e-06	9.58e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ACHE—Alzheimer's disease	9.59e-06	9.38e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCA1—Alzheimer's disease	9.58e-06	9.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—TPI1—Alzheimer's disease	9.55e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CHAT—Alzheimer's disease	9.55e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—MTHFR—Alzheimer's disease	9.54e-06	9.34e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	9.48e-06	9.28e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—GSK3B—Alzheimer's disease	9.19e-06	8.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MAOB—Alzheimer's disease	9.15e-06	8.96e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CREB1—Alzheimer's disease	9.11e-06	8.92e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—Alzheimer's disease	9.06e-06	8.87e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ENO1—Alzheimer's disease	8.99e-06	8.79e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	8.99e-06	8.79e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CALM1—Alzheimer's disease	8.92e-06	8.72e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOE—Alzheimer's disease	8.88e-06	8.69e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	8.82e-06	8.62e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	8.81e-06	8.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAV1—Alzheimer's disease	8.8e-06	8.61e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—A2M—Alzheimer's disease	8.51e-06	8.33e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—BCHE—Alzheimer's disease	8.36e-06	8.18e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	8.25e-06	8.07e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HMOX1—Alzheimer's disease	8.22e-06	8.04e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—Alzheimer's disease	7.95e-06	7.77e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	7.89e-06	7.71e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—Alzheimer's disease	7.74e-06	7.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.74e-06	7.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	7.64e-06	7.48e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—Alzheimer's disease	7.59e-06	7.42e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—LPL—Alzheimer's disease	7.51e-06	7.35e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ACHE—Alzheimer's disease	7.4e-06	7.24e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	7.32e-06	7.16e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ENO1—Alzheimer's disease	6.94e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	6.94e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	6.8e-06	6.66e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—MTHFR—Alzheimer's disease	6.77e-06	6.62e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—Alzheimer's disease	6.66e-06	6.51e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	6.59e-06	6.44e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	6.56e-06	6.42e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—BCHE—Alzheimer's disease	6.45e-06	6.31e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CALM1—Alzheimer's disease	6.32e-06	6.18e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOE—Alzheimer's disease	6.3e-06	6.16e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAV1—Alzheimer's disease	6.24e-06	6.1e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	6.09e-06	5.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—LPL—Alzheimer's disease	6e-06	5.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	5.9e-06	5.77e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—Alzheimer's disease	5.49e-06	5.37e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	5.4e-06	5.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—Alzheimer's disease	5.38e-06	5.26e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—Alzheimer's disease	5.26e-06	5.14e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.08e-06	4.97e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.06e-06	4.95e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CALM1—Alzheimer's disease	5.05e-06	4.94e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOE—Alzheimer's disease	5.03e-06	4.92e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAV1—Alzheimer's disease	4.98e-06	4.87e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—Alzheimer's disease	4.72e-06	4.62e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—LPL—Alzheimer's disease	4.63e-06	4.53e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—Alzheimer's disease	4.38e-06	4.28e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—Alzheimer's disease	4.32e-06	4.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—Alzheimer's disease	4.3e-06	4.2e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.17e-06	4.08e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—Alzheimer's disease	3.96e-06	3.87e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.89e-06	3.81e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.88e-06	3.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.84e-06	3.76e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—Alzheimer's disease	3.77e-06	3.68e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—AKT1—Alzheimer's disease	3.65e-06	3.57e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	3.45e-06	3.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.38e-06	3.31e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—Alzheimer's disease	3.31e-06	3.24e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—AKT1—Alzheimer's disease	3.06e-06	2.99e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.91e-06	2.84e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.66e-06	2.6e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.17e-06	2.12e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.73e-06	1.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.34e-06	1.31e-05	CbGpPWpGaD
